Correspondence 0001213900-22-070481 from ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc.
Date: Nov. 9, 2022 · CIK: 0001921865 · Accession: 0001213900-22-070481
AI Filing Summary & Sentiment
File numbers found in text: 333-267392
Show Raw Text
CORRESP
1
filename1.htm
650 Fifth
Avenue, 35th Floor
New York, NY 10019
November
9, 2022
VIA EDGAR CORRESPONDENCE
U.S. Securities and
Exchange
Commission Division of Corporation
Finance 100 F Street, N.E.
Washington, D.C. 20549
Attention: Jordan Nimitz
Margaret Schwartz
Re: ASP Isotopes Inc.
Registration
Statement on Form S-1
File No. 333-267392
REQUEST FOR ACCELERATION
OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), Revere Securities
LLC, as representative of the underwriters of the offering, hereby joins the request of ASP Isotopes Inc. that the effective date of the
above referenced Registration Statement on Form S-1 be accelerated so that it may become effective at 4:00 p.m., Eastern Time, on Wednesday,
November 9, 2022, or as soon thereafter as practicable.
Pursuant to Rule 460 under
the Act, we wish to advise you that the underwriters have distributed as many copies of the preliminary prospectus to underwriters,
dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms
that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that
they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection
with the above-referenced issue.
Best Regards,
REVERE SECURITIES LLC
By:
/s/ Thomas Irwin
Name:
Thomas Irwin
Title:
Chief Operations Officer